Insider buying last 90 days
No open-market insider purchases were filed for SCL in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every SCL insider filing, plotted on the chart in Gekko.Open SCL in Gekko
Gekko Brief
AI summaryOct 12 closeThis week's attention around Stepan centers on its upcoming third-quarter 2026 earnings, confirmed for October 28, alongside comparisons drawn against peers Air Products and Chemicals and PureCycle Technologies covering dividends, valuation and profitability. A recent earnings report showing 15% revenue growth to $684.11 million and adjusted EPS of $1.18 beating estimates was followed by an upgrade to Strong Buy with an $85.00 price target. Separately, an adviser disclosed a 5.2% passive stake in Stepan through various funds.
Stepan closed at $60.80, down 0.4%, sitting between its 50-day average of $62.96 and 200-day average of $55.80, with a mixed trend picture. The stock's one-year return stands at 26.3%, though the one-month return is -1.3%. The GekkoIndex reads 63, placing it in the Accumulation zone, and the gap to Gekko Fair Value of $71.82 stands at -15.3%.
Earnings are scheduled for 28 October 2026, before the open, falling inside the next 20 trading days and following a prior quarter where actual EPS of -$0.02 missed the $0.35 estimate, with an average absolute reaction of 7.1% historically. Seasonality over this stretch has averaged a 7% gain across 5 years, with gains in 4 of them. No insider, Congress or unusual options activity appears in the respective windows. The sole analyst consensus target stands at $85.00, implying 39.8% upside.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Stepan price vs fair value
Close $60.80200-day averageGekko Fair Value $71.82
Stepan quick facts
- Market cap
- $1.38B
- P/E ratio
- —
- Forward P/E
- 17.5
- EPS, TTM
- −$0.12
- Revenue, TTM
- $2.43B
- Profit margin
- -0.1%
- Dividend yield
- 2.56%
- Beta
- 0.95
- Volume
- 153,814 avg 160,190
- 1-year return
- +26.3%
- Typical daily move
- ±2.6%
- Typical 20-day move
- ±5.5%
- 50-day average
- $62.96
- 200-day average
- $55.80
- Next earnings
- Oct 28 before open
- Shares outstanding
- 22.71M
Stepan swing-trade checklist
Stepan scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
- Trendmixed
Averages disagree
Close $60.80 sits between the 50-day ($62.96) and 200-day ($55.80) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
63, Accumulation
Reading 63 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
15.3% below
Price is 15.3% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 16 days
Reports on Oct 28, 2026, 16 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+7.0% on average
From this point in the calendar, the next 20 trading days averaged +7% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Stepan stock chart and price history
Stepan closed at $60.80 on Oct 12, 2026, +26.3% over the past year, inside a 52-week range of $41.82 to $68.00.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −1.3%
- 3 months
- +6.9%
- 6 months
- +16.1%
- 1 year
- +26.3%
The full SCL chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open SCL in Gekko
Follow Stepan through every session
Put SCL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track SCL in GekkoFree for 7 days. No credit card required.
About Stepan
Stepan makes chemical ingredients that other manufacturers build into finished goods, rather than selling directly to consumers. Its products turn up in everyday items such as laundry and dish detergents, shampoos, body washes, fabric softeners and disinfectants, and it also supplies emulsifiers used to help agricultural products spread evenly and ingredients used in plastics and composite materials. The company is perhaps most closely tied to this kind of surfactant chemistry, which underpins a wide range of household and industrial cleaning products.
Beyond surfactants, Stepan is organized into two further areas of business. One produces polyols and resins used to make rigid insulation foam for buildings, along with materials for coatings, adhesives, sealants and elastomers, plus phthalic anhydride used in construction, automotive and boating applications. The other supplies flavors, emulsifiers and solubilizers for food, nutritional supplement and pharmaceutical uses. Its customer base spans manufacturers across these industries in the United States and in countries including France, Poland, the United Kingdom, Brazil and Mexico, among others.
Stepan traces its founding to 1932 and operates out of Northbrook, Illinois. Its shares are listed on the NYSE under the ticker SCL.
- Listed
- NYSE
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Website
- stepan.com
Stepan GekkoIndex: the smart money zone
Stepan’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 63, in the Accumulation zone, up 6.2 points over five sessions.
63Accumulation
Up 6.2 points over five sessions, from the Neutral zone.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 49 | −0.2% | +1.2% | ||
| Accumulation (current zone) | 256 | +0.2% | −0.7% | ||
| Neutral | 342 | −0.7% | −1.1% | ||
| Distribution | 29 | +2.2% | +1.2% | ||
| Selling | 6 | Too few readings yet | |||
Average SCL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the SCL price, zone by zone.Track SCL in Gekko
Is Stepan stock overvalued? Gekko Fair Value
Stepan trades 15.3% below Gekko Fair Value of $71.82, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Stepan shares are worth, recalculated every trading day.
$71.82
Gekko Fair Value, Oct 10, 2026
15.3% Undervalued
At the end of Aug 2026 the price was 18.0% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open SCL in Gekko
Stepan insider and Congress trading
No open-market insider purchases were filed for Stepan, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in SCL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for SCL, plotted on the chart in Gekko.Open SCL in Gekko
Buybacks
Stepan has been buying back its own shares.
- Bought back, quarter ended Dec 31, 2022
- $2.69M
- As a share of market cap
- 0.19%
- Trailing four quarters
- $24.95M
From company filings.
Stepan earnings: next date and track record
Stepan reports on Oct 28, 2026, before the open (16 days away), and beat the EPS estimate in 3 of its last 8 reports.
Next earnings report
Oct 28, 2026
Expected before the open, 16 days away
- EPS estimate
- $0.73
- Revenue estimate
- $634.3M
3 of 8reports beat the EPS estimate
±7.1%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Feb 23, 2026 AI summary
- What they said
- Stepan Company reported Q4 2025 adjusted net loss of $500K ($0.02 per share) versus prior year, though full-year adjusted EBITDA grew 6% to $199M despite challenging macro conditions. The company divested two manufacturing plants, commissioned the Pasadena alkoxylation facility, and achieved 58 consecutive years of dividend increases with 2.6% growth. Organic volumes increased 2% driven by crop productivity and polymers growth, while leverage improved from 2.8x to 2.5x.
- Guidance
- Management positioned the company to execute a more disciplined and resilient operating model in 2026 and beyond through foundational optimization work and Project Catalyst implementation. The company maintained confidence in long-term cash flow strength.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Feb 23, 2026 | −$0.02 est $0.35 | $553.9M est $570.6M | −21.9% |
| Oct 29, 2025 | $0.48 est $0.36 | $590.3M est $570.6M | −3.2% |
| Jul 29, 2025 | $0.52 est $0.90 | $594.7M est $585.5M | −11.2% |
| Apr 28, 2025 | $0.84 est $0.96 | $593.3M est $593.0M | +7.0% |
| Feb 18, 2025 | $0.12 est $0.62 | $525.6M est $581.4M | +1.3% |
| Oct 30, 2024 | $1.03 est $0.65 | $546.8M est $530.3M | −0.8% |
| Jul 31, 2024 | $0.41 est $0.67 | $556.4M est $589.8M | −11.0% |
| Apr 30, 2024 | $0.64 est $0.35 | $551.4M est $575.8M | −0.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Stepan stock forecast and analyst price targets
Analysts’ average 12-month price target for Stepan is $85.00, +39.8% from the last close, from 1 firm rating the stock in the last 90 days.
$85.00consensus 12-month target, +39.8% from the last close
Each firm’s latest rating in the last 90 days: 1 firm.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 7 | Seaport Global | $85 | +39.8% |
−0.7%average 20-day move after past Accumulation readings
+7.0%average move over the next 20 trading days in the last 5 years
±2.6%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Stepan seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Stepan averaged +7.0% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.3% | 2 of 5 |
| Next 10 trading days | +1.9% | 3 of 5 |
| Next 15 trading days | +3.1% | 4 of 5 |
| Next 20 trading days | +7.0% | 4 of 5 |
| Next 30 trading days | +6.4% | 4 of 5 |
For scale, SCL’s typical 20-trading-day move in either direction is about 5.5%.
Stepan market cap and key statistics
Stepan’s market cap is $1.38B and revenue of $2.43B over the last twelve months.
Valuation
- Market cap
- $1.38B
- Forward P/E
- 17.5
- EPS, TTM
- −$0.12
- Gekko Fair Value
- $71.82
Trading
- Volume
- 153,814
- Avg volume, 20 days
- 160,190
- 52-week high
- $68.00
- 52-week low
- $41.82
- Shares outstanding
- 22.71M
Financials
- Revenue, TTM
- $2.43B
- Profit margin
- -0.1%
- Return on equity
- -0.2%
- Quarterly earnings growth, YoY
- +101.6%
Risk and income
- Beta
- 0.95
- Typical daily move
- ±2.6%
- Typical 20-day move
- ±5.5%
- Dividend yield
- 2.56%
Stepan stock news this week
Coverage of Stepan this week reads neutral: 2 positive, 3 neutral and 0 negative headlines.
- Critical Review: Stepan (NYSE:SCL) vs. Air Products and Chemicals (NYSE:APD)Defense World, Oct 11
- One adviser reports a passive stake above 5% in Stepan (SCL) across multiple funds.Stock Titan, Oct 8
- Stepan to Announce Third Quarter 2026 Results on October 28, 2026www.marketscreener.com, Oct 8
- Stepan to issue Q3 2026 earnings results on Oct. 28Stock Titan, Oct 7
- Financial Comparison: Stepan (NYSE:SCL) vs. PureCycle Technologies (NASDAQ:PCT)Defense World, Oct 7
- Zacks upgrades Stepan Company stock to Strong BuyAD HOC NEWS, Oct 6
Stepan peers
Stepan’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LINLinde | Neutral | 0.3% below |
| ECLEcolab | Neutral | 9.4% above |
| APDAir Products and Chemicals | Accumulation | 9.5% below |
| DOWDow | Accumulation | 33.5% below |
| LYBLyondellBasell Industries | Accumulation | 10.6% below |
| ALBAlbemarle | Accumulation | 29.6% below |
A peer links to its own page where one exists.
Stepan stock FAQ
What is Stepan’s market cap?
Stepan’s market cap is $1.38B at the Oct 12, 2026 close of $60.80, with 22.71M shares outstanding.
What is the Stepan stock forecast?
The consensus analyst 12-month price target for Stepan is $85.00, +39.8% from the last close. Of the 1 firm that rated the stock in the last 90 days, 1 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Stepan stock overvalued or undervalued?
On Gekko’s estimate Stepan is undervalued: the Oct 12, 2026 close of $60.80 is 15.3% below Gekko Fair Value of $71.82. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Stepan report earnings next?
Stepan is expected to report on Oct 28, 2026, before the market opens (16 days away). Analysts expect earnings of $0.73 per share on revenue of $634.3M. Stepan beat the earnings estimate in 3 of its last 8 reports, moving 7.1% on average across the report.
What is Stepan’s 52-week high and low?
Stepan’s 52-week high is $68.00 and its 52-week low is $41.82; it closed at $60.80 on Oct 12, 2026, +26.3% over the past year. Over the last five years the shares peaked at $129.35 on Nov 8, 2021.
Is Stepan stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and seasonality), 1 as mixed (trend) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Stepan the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.